NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category

Market
Jun.23
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs data show U.S. smokeless nicotine product sales rose more than 8% year over year in the 52 weeks ended May 30, making it the only major nicotine category to record growth.

Key Points

  • NielsenIQ data show smokeless grew over 8%.
  • Cigarettes still account for nearly 70% of sales.
  • Grand View sees pouch CAGR near 25%.
  • FDA has authorized ZYN and on! PLUS products.

2Firsts

June 23, 2026

According to C-Store Dive, as cigarette use and sales continue to decline in the United States, smokeless nicotine products are gaining more attention in the convenience-store channel, with nicotine pouches becoming one of the fastest-growing and most closely watched segments.

Smokeless Products Keep Growing

The report said the smokeless category includes products such as chewing tobacco, snuff, snus and nicotine pouches. Nicotine pouches have become a particular focus for the convenience-store industry. According to Grand View Research, U.S. nicotine pouch sales are expected to grow at a compound annual growth rate of nearly 25% through 2033.

However, smokeless products are still not the largest part of the U.S. nicotine business. NielsenIQ and Goldman Sachs data showed that in the 52 weeks ended May 30, U.S. cigarette sales fell 2.4% year over year, but cigarettes still accounted for nearly 70% of total nicotine category sales.

Smokeless nicotine products were the second-largest segment of the nicotine category. C-Store Dive said smokeless products were also the only major nicotine category to record growth over the past year, with full-year sales up more than 8%. By comparison, cigar sales fell about 1%, cigarette sales declined by more than 2%, and vape sales recorded a double-digit reduction.

The shift shows that the nicotine backbar in convenience stores is changing. Cigarettes remain dominant, but growth momentum is moving gradually from combustible tobacco toward smokeless products, especially modern oral nicotine products.

Three Companies Lead the Market

C-Store Dive reported that Altria Group, British American Tobacco and Swedish Match, a division of Philip Morris International, together account for more than 90% of the smokeless nicotine category.

Altria has a U.S. smokeless portfolio that includes traditional smokeless tobacco and modern oral products, including Copenhagen, Skoal and on!. British American Tobacco competes through traditional smokeless brands such as Grizzly and modern oral products. Swedish Match, now owned by Philip Morris International, has expanded rapidly in the U.S. market through ZYN nicotine pouches.

The report said Altria Group still leads in annual sales, but Swedish Match is catching up. ZYN has been available for longer, and the popularity of its nicotine pouches is reflected in year-over-year sales data. on! PLUS entered wider distribution only in March 2026, so the Goldman Sachs data did not list its year-over-year sales change.

For convenience stores, nicotine pouch growth means shelf allocation and category management are changing. As traditional cigarette sales decline, retailers need to rebalance display space and promotional resources across cigarettes, vapes, traditional smokeless tobacco and nicotine pouches.

FDA Authorizations Raise Compliance Focus

Regulatory attention on nicotine pouches is also increasing. In January 2025, the U.S. Food and Drug Administration (FDA) authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product application (PMTA) pathway. It was the first time the FDA had authorized products commonly referred to as nicotine pouches.

In December 2025, the FDA authorized six on! PLUS nicotine pouch products, including mint, wintergreen and tobacco flavors in 6 mg and 9 mg nicotine strengths. The applications were submitted by Altria’s Helix Innovations. The FDA said the authorizations were the first decisions under its nicotine pouch PMTA pilot program, which is intended to improve review efficiency while maintaining scientific standards.

FDA marketing authorization does not mean a product is “safe” or “FDA approved.” The agency generally says an authorization means a product meets the statutory “appropriate for the protection of public health” standard based on a specific application and regulatory conditions, while companies must still comply with marketing, age-restriction and post-market requirements.

For the U.S. convenience-store industry, the authorizations for ZYN and on! PLUS carry market signals. On one hand, nicotine pouches may offer adult tobacco or nicotine users a non-combustible alternative. On the other hand, regulators continue to scrutinize youth use, flavor appeal, marketing practices and labeling compliance.

From an industry perspective, the growth of smokeless nicotine products is reshaping competition in the U.S. nicotine market. Convenience stores still depend heavily on cigarettes for sales scale, but future category growth is more likely to come from modern oral products such as nicotine pouches. As more products move through PMTA review and authorization pathways, compliance status, brand concentration and channel execution will become key competitive factors in the smokeless nicotine market.

(Cover Image source: C-Store Dive)


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
Philip Morris International (PMI) has confirmed plans to bring its IQOS heated tobacco device to Argentina by the end of 2026, after the Argentine government lifted long-standing restrictions and created a regulatory framework for heated tobacco, e-cigarettes and nicotine pouches.
News
Jun.26 by 2Firsts Perspectives
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
According to China Customs export data analyzed by 2Firsts, China’s vape export mix continued to evolve during January-May 2026. Exports of electronic vaporisation devices (HS 85434000) increased 13.00% year on year, supported by growth in both shipment volume and average export prices. Meanwhile, exports of nicotine-containing non-combustible products (HS 24041200) declined 6.89%, with lower shipment volumes partly offset by higher average export prices.
Special Report
Jun.30
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
China’s vape-related exports fell 10.25% year on year in May 2026, marking a second consecutive monthly decline, although exports recovered modestly from April. January-May exports totaled US$4.018 billion, down 0.86% from a year earlier and broadly in line with 2025 levels.
Special Report
Jun.29
2Firsts Data | China’s U.S. Vape Exports Have Yet to Regain Previous Growth Momentum in H1 2026, but Hardware Grew 15.2% and 6-Methyl Nicotine-Related Products Rose 234.7%
2Firsts Data | China’s U.S. Vape Exports Have Yet to Regain Previous Growth Momentum in H1 2026, but Hardware Grew 15.2% and 6-Methyl Nicotine-Related Products Rose 234.7%
China’s vape exports to the U.S. reached approximately $1.58 billion in the first half of 2026, remaining broadly stable from a year earlier but still below previous growth momentum. 2Firsts’ analysis of China Customs data shows that the U.S. market has not simply returned to its previous trajectory after the enforcement shock and inventory-driven swings of 2025. Instead, export momentum is shifting across product categories. Vaping devices and atomization hardware increased 15.2% year over year, while 6-methyl nicotine-related and other nicotine substitute products surged 234.7%. Meanwhile, traditional nicotine-containing vaping products continued to face pressure.
Jul.22
Korean component maker ITM Semiconductor says Indonesia unit starts e-cigarette device output as related Q1 revenue rises 55.4%
Korean component maker ITM Semiconductor says Indonesia unit starts e-cigarette device output as related Q1 revenue rises 55.4%
South Korea’s KOSDAQ-listed electronics-component maker ITM Semiconductor said its Indonesia subsidiary has begun full-scale mass production of e-cigarette devices, with first-quarter revenue from the business rising 55.4% year on year to 42.1 billion won, Maeil Business Newspaper reported.
Jul.08
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
According to China Customs export data analyzed by 2Firsts, the United States remained China’s largest destination for vape-related exports during January-May 2026 despite a 13.82% year-on-year decline in export value. Meanwhile, exports to Japan, Russia, Indonesia and the United Arab Emirates recorded strong growth, highlighting continued diversification across China’s export markets.
Special Report
Jun.29